MultiCell Technologies, Inc. (MCET)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2014 | -518.04 Thousand USD | 156.91% |
| 2013 | -1.36 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2015 Q3 | -176.91 USD | -177.58% |
| 2015 Q1 | 26.59 USD | -88.87% |
| 2015 Q2 | 228.03 USD | 757.64% |
| 2014 Q3 | 26.34 USD | -45.56% |
| 2014 Q2 | 48.38 USD | 65.49% |
| 2014 Q4 | 238.78 USD | 806.53% |
| 2014 FY | - USD | 156.91% |
| 2014 Q1 | 29.24 USD | -47.25% |
| 2013 FY | - USD | 0.0% |
| 2013 Q3 | 40.69 USD | 0.0% |
| 2013 Q4 | 55.43 USD | 36.21% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 99.271% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | 91.262% |
| SQZ Biotechnologies Company | -64.14 Million USD | 99.192% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 97.018% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 100.551% |
| Mesoblast Limited | -62.38 Million USD | 99.17% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 66.274% |
| Genus plc | 73.7 Million USD | 100.703% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | 92.164% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | 85.395% |
| Marizyme, Inc. | -34.28 Million USD | 98.489% |
| ContraFect Corporation | -64.99 Million USD | 99.203% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 94.094% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | 88.554% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 63.044% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | 80.41% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | 77.707% |
| Accustem Sciences Inc. | -3.74 Million USD | 86.172% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 98.926% |
| EV Biologics, Inc. | -1.26 Million USD | 59.117% |
| Q BioMed Inc. | -617.62 Thousand USD | 16.123% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 114.503% |
| Neon Bloom, Inc. | -632.4 Thousand USD | 18.083% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | 77.323% |
| Biomind Labs Inc. | -1.03 Million USD | 49.925% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 105.245% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | 92.766% |
| Skye Bioscience, Inc. | -13.54 Million USD | 96.176% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | 65.171% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -1972.184% |
| Arch Therapeutics, Inc. | -3.88 Million USD | 86.663% |
| IMV Inc. | -35.52 Million USD | 98.542% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 96.736% |
| Curative Biotechnology, Inc. | -2.5 Million USD | 79.294% |
| GB Sciences, Inc. | -1.41 Million USD | 63.515% |
| Alpha Cognition Inc. | -9.7 Million USD | 94.662% |
| HST Global, Inc. | -5303.00 USD | -9668.923% |
| CSL Limited | 4.78 Billion USD | 100.011% |
| Halberd Corporation | -74.27 Thousand USD | -597.433% |
| Enzolytics Inc. | -2.12 Million USD | 75.587% |
| Resverlogix Corp. | -11.74 Million USD | 95.588% |
| Affymax, Inc. | -14.29 Million USD | 96.376% |
| SYBLEU INC | -141.57 Thousand USD | -265.927% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | 83.087% |
| argenx SE | -216.02 Million USD | 99.76% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 99.064% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 142.567% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | 65.438% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 236.744% |
| AVAX Technologies, Inc. | -6.11 Million USD | 91.525% |
| Zenith Capital Corp. | -8.6 Million USD | 93.98% |
| Genscript Biotech Corporation | -248.71 Million USD | 99.792% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -2873.687% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | 78.825% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -194.304% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 98.693% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | 82.089% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | 50.488% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 7804.432% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | 70.397% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | 73.031% |
| BioStem Technologies, Inc. | -7.55 Million USD | 93.142% |
| ONE Bio Corp. | 13.61 Million USD | 103.806% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -186.074% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | 74.815% |
| Agentix Corp. | -1.37 Million USD | 62.235% |
| LadRx Corporation | 412.28 Thousand USD | 225.653% |
| Cell Source, Inc. | -4.27 Million USD | 87.875% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -41.072% |
| Regen BioPharma, Inc. | 1.46 Million USD | 135.338% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | 44.709% |
| NovAccess Global Inc. | -1.03 Million USD | 49.937% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 105.851% |
| Itoco Inc. | -1.86 Million USD | 72.282% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -36.464% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | 53.58% |
| Kadimastem Ltd | -2.62 Million USD | 80.26% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -116.62% |
| CytoDyn Inc. | -18.02 Million USD | 97.127% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -555.514% |
| Mobile Lads Corp. | -2.24 Million USD | 76.885% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -4136.209% |
| Qrons Inc. | -40.08 Thousand USD | -1192.498% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -6.664% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 198.22% |
| Rebus Holdings, Inc. | -951 Thousand USD | 45.526% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | 51.22% |
| International Stem Cell Corporation | 202 Thousand USD | 356.458% |
| Bioxytran, Inc. | -3.82 Million USD | 86.439% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -884.13% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | 78.958% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 98.556% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -1051.213% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | 81.079% |
| Neutra Corp. | -181.24 Thousand USD | -185.823% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 97.43% |
| PureTech Health plc | -11.62 Million USD | 95.544% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 97.43% |
| IXICO plc | -707 Thousand USD | 26.726% |
| IntelGenx Technologies Corp. | -7.68 Million USD | 93.259% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 98.928% |
| CSL Limited | 4.73 Billion USD | 100.011% |
| Cellectis S.A. | -92.63 Million USD | 99.441% |